INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Abbott Laboratories
Back to Newsroom
🏢Organization Dossier

Abbott Laboratories

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

7 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Markets & Equities 22 Oct 2026, 02:00 PM IST

Abbott Cuts 2026 Sales Outlook and Moves to Spin Off Nutrition Unit

Abbott Laboratories lowered its 2026 sales growth outlook and said it will separate its nutrition business into an independent company, marking a major strategic reset for one of the world’s largest healthcare conglomerates. The move comes as the company seeks to sharpen its portfolio after years of scrutiny over its infant formula operations and as investors reassess the growth profile of the broader business.

By RDU Global Wire6 min read
Startups & Venture Capital18 Nov 2026, 08:00 PM IST

Jitendra Singh Launches IISF 2026 Curtain Raiser, Urges Science to Reach Beyond Laboratories

Union Minister Dr. Jitendra Singh launched the curtain-raiser for the India International Science Festival (IISF) 2026, framing the event as a platform to take science out of laboratories and into everyday public life. He called for stronger engagement with youth, startups, and innovators, positioning scientific communication as a tool for national development and broader participation in India’s innovation economy.

5 min readRead →
Healthcare, Pharma & Life SciencesJust now (07:14 PM IST)

Linux Laboratories Raises $70 Million from ChrysCapital and Tata Capital Healthcare Fund

Linux Laboratories has secured $70 million in fresh funding from ChrysCapital and Tata Capital Healthcare Fund, marking a significant vote of confidence in India’s pharmaceutical manufacturing and specialty healthcare ecosystem. The company said it will deploy the capital to deepen its presence in core specialties, enter new therapeutic areas, and expand manufacturing capacity as it scales for the next phase of growth.

4 min readRead →
Startups & Venture CapitalJust now (06:10 AM IST)

Silence Laboratories bets on cryptographic trust as India’s data economy scales

Silence Laboratories is positioning itself at the intersection of privacy, enterprise software and deep tech with a model that replaces traditional legal contracts and intermediaries with cryptographic guarantees. The startup’s pitch is simple but consequential: enable joint computations on encrypted data without exposing raw inputs, a capability that could reshape how regulated industries collaborate on sensitive information. As India’s startup market matures beyond consumer internet plays, the company’s approach reflects a broader shift toward infrastructure businesses built on trust, compliance and data security. In a market where data sharing is both commercially valuable and legally fraught, cryptographic computation could become a foundational layer for the next generation of enterprise software.

5 min readRead →
Startups & Venture Capital7h ago

Silence Laboratories Bets on Cryptography to Secure Data for the Quantum Era

Palo Alto-based Silence Laboratories is building privacy-first infrastructure that lets organisations compute on sensitive data without exposing the raw information, using Multi-Party Computation and Zero-Knowledge Proofs. The startup says its technology is already serving clients across banking, fintech and digital assets, while it prepares for the next wave of quantum-era security threats.

5 min readRead →
Clean Energy & Climate Transition18 Nov 2026, 08:00 AM IST

How Avogadro’s Number Became a Fixed Constant—and Why It Still Matters

Avogadro’s number, long treated as a cornerstone of chemistry, did not become a fixed constant by accident. Its path to definition reflects a century of measurement advances, international standard-setting, and the push to make the International System of Units more precise and universally reproducible. The result matters far beyond laboratories, shaping everything from materials science to the calibration of clean-energy technologies.

5 min readRead →
Markets, IPOs & Wealth17 Nov 2026, 02:00 PM IST

Dr. Reddy’s Shares Edge Higher in Cautious Trade as Investors Reassess Pharma Valuations

Dr. Reddy’s Laboratories saw a modest uptick in its share price in afternoon trade, reflecting a measured rebound in a sector that has been under close scrutiny for pricing, earnings visibility and export demand. The move was not dramatic, but it signalled that investors remain willing to accumulate quality pharmaceutical names on dips even as broader market sentiment stays selective.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Abbott Laboratories: